Search

Metallic catalysts have emerged as prominent materials for graphene growth because the choice of the substrate significantly influences the properties of graphene. Among metallic catalysts, Cu is a highly promising catalytic substrate because it facilitates the growth of monolayer graphene. However, the growth process often induces strain and structural deformations that affect the electronic properties and device performance of graphene. In this study, we present the first observation of micropatterned strain domains in graphene grown on Cu substrates using chemical vapor deposition. Distinct strain‐induced shifts and broadening in the Raman peaks by employing Raman spectroscopy and atomic force microscopy are revealed, demonstrating the unique structural characteristics within the patterned domains. Furthermore, a strong correlation between the strain patterns in graphene and the facet structures of the underlying Cu surface is established. Our findings reveal intriguing variations in strain within the patterned domains and along the line boundaries, offering valuable insights into the intricate interactions between graphene and the Cu surface. These observed strain patterns and their spatial correlations with the Cu facet structures provide crucial guidance for designing graphene‐based devices with tailored strain engineering. [ABSTRACT FROM AUTHOR]

Recent studies concerning graphene quantum dots (GQDs) focus extensively on their application in biomedicine, exploiting their modifiable optical properties and ability to complex with various molecules via π–π or covalent interactions. Among these nascent findings, the potential therapeutic efficacy of GQDs was reported against Parkinson's disease, which has to date remained incurable. Herein, we present an environmentally friendly approach for synthesizing GQDs through a waste-to-treasure method, specifically from coffee waste to nanodrug. Consistent with the previous findings with carbon fiber-derived GQDs, the inhibitory effects of coffee bean-derived GQDs demonstrated similar effectiveness against abnormal α-synuclein fibrillation and the protection of neurons from relevant subcellular damages. The fact that a GQDs-based nanodrug can be prepared from a non-reusable yet edible source illustrates a potential approach to convert such waste materials into novel therapeutic agents with minimal psychological rejection by patients. [ABSTRACT FROM AUTHOR]